8 analysts have shared their evaluations of Merck & Co (NYSE:MRK) during the recent three months, expressing a mix of bullish and bearish perspectives.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 2 | 4 | 2 | 0 | 0 |
Last 30D | 0 | 1 | 0 | 0 | 0 |
1M Ago | 0 | 1 | 0 | 0 | 0 |
2M Ago | 2 | 1 | 1 | 0 | 0 |
3M Ago | 0 | 1 | 1 | 0 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $144.12, a high estimate of $155.00, and a low estimate of $125.00. This current average represents a 2.29% decrease from the previous average price target of $147.50.
Interpreting Analyst Ratings: A Closer Look
The standing of Merck & Co among financial experts is revealed through an...
Login or create a forever free account to read this news
Sign up/Log in